chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe headache lasting for 16 hours, took Tylenol but did not help Body aches and soreness lasting 24 hours Diarrhea lasting for 24 hours
Pt received vaccine on 5/8/00 and approximately 4-5 hours late developed multiple 1mm erythematous papules on extremities, chest, abdomen and back. No fever was noted. No other symptoms.
8 hrs post vaccine- 6/3 -Site pain and fatigue 24 hrs post vaccine-6/4- stiff neck  48hrs post- 6/5 severe chest pain- went to ER, 6/5 20:00 Admitted to Hospital
Difficult breathing night after shot; Feel very sick everyday- still lasting- can't do day to day things; Feel very sick everyday- still lasting- can't do day to day things; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 15:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and fibromyalgia. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 16:00, the patient felt difficult breathing night after shot and felt very sick everyday which was still lasting at the time of report and the patient could not do day to day things. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt difficult breathing night after shot, felt very sick everyday which was still lasting at the time of report and could not do day to day things was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Lethargic, whiny, poor appetite, t104 x 2 days; Friday OK Sat vomited seen by MD Tuesday poor appetite & lethargy; Seemed better x/anorexia until 22SEP91; irritable, runny nose, t104, whiney;
He has had raised pimples on his arms, neck, thighs, top of his legs; Circular rash around his neck, itches like hell; Circular rash around his neck; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ACNE (He has had raised pimples on his arms, neck, thighs, top of his legs), RASH PRURITIC (Circular rash around his neck, itches like hell) and RASH (Circular rash around his neck) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD, Heart disorder and Asthma. Concomitant products included ATENOLOL, CLOPIDOGREL, GABAPENTIN, AMLODIPINE, ATORVASTATIN, METFORMIN, MONTELUKAST, ZOLPIDEM, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), LOSARTAN, TAMSULOSIN and VITAMINS NOS for an unknown indication.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ACNE (He has had raised pimples on his arms, neck, thighs, top of his legs), RASH PRURITIC (Circular rash around his neck, itches like hell) and RASH (Circular rash around his neck). The patient was treated with TRIAMCINOLONE ACETONIDE at an unspecified dose and frequency and NYSTATIN at an unspecified dose and frequency. At the time of the report, ACNE (He has had raised pimples on his arms, neck, thighs, top of his legs), RASH PRURITIC (Circular rash around his neck, itches like hell) and RASH (Circular rash around his neck) outcome was unknown.            Concomitant medications include aspirin 81 mg. The patient received the both doses given by the local fire men in his building .  Treatment information includes a fungal powder Nystatin at night. He had been taking two topical medications and it stops and breaks out again. He went to the dermatologist and had told that it is the effect from the shot. He said that a bunch of his friends had it too.  The patient needs an advice that should he take a booster shot before he finds out how to treat what he has.
Localized reaction: Within 6 hours of the injection a warm, red, itchy welt appeared at the injection site. It was the size of a quarter with a lump under the skin about the size of a half dollar. Within 24 hours, both the welt and the lump doubled in size.  Side Effects: Within 2 hours of the vaccine a headache developed.  Within 4 hours of the vaccine fatigue set-in.  24 hours after receiving the vaccine, fatigue continued.  34 hours after receiving the vaccine, in addition to the continued fatigue, shortness of breath, dyspnea upon exertion started a long with mild throat soreness, nausea, muscle/body aches and joint pain.  50 hours after receiving the vaccine all side effects subsided except for soreness at the site of the injection and shortness of breath/dyspnea.  72 hours after receiving the vaccine there is still soreness at the site of the injection as well as shortness of breath.
Nine days after vaccination, developed a warm erythematous rash on left arm just below the vaccine site which has spread over 3 days to involve the lateral arm down to near the elbow.  Now 12 days since the vaccine was given.
According to patient injection was given near (R) elbow. Red rash over elbow painful not itchy. Pt. lethargic, chills, stated "just don't feel well".
This case was reported by a physician, via a GSK sales representative, that described the occurrence of excessive screaming in a 4-month-old subject of unspecified gender who was vaccinated with PEDIARIX, GlaxoSmithKline.  In March 2008, the subject received the 2nd dose of PEDIARIX (.5 ml, unknown, right thigh).  Within one hour after vaccination with PEDIARIX, the subject experienced a screaming reaction, described as "unconsolable non-stop screaming", which lasted for a period of several hours.  At the time of reporting the event was resolved.  The reporting physician considered the event was probably related to vaccination with PEDIARIX.  Follow-up information was received on 23 May 2008 via a registered nurse, who indicated that this case was reported to a Regulatory Agency (VAERS ID # was not reported).  The nurse reported that the subject was a 12-month-old female who was vaccinated with PEDIARIX on 28 March 2008.  The subject's medical history included gastroesophageal reflux.  Concurrent medical conditions included allergic rhinitis.  Concurrent vaccinations given on 28 March 2008 included ACTHIB, manufacturer unspecified; unknown; left thigh; and PREVNAR, manufacturer unspecified; unknown; left thigh.  Concurrent medications included Singulair and Zantac.  In addition to the previously reported excessive screaming, on 28 March 2008, at an unspecified time after vaccination with PEDIARIX, the subject experienced a fever and fussiness.  The subject's fever was reported to range from 102 to 103 degrees Fahrenheit for a period of four days, before resolving on 31 March 2008.  The fussiness and excessive screaming were also reported to last for a period of four days, before resolving on 31 March 2008.  As of 01 April 2008, all of the symptoms were reported to be resolved.  The immunization series with PEDIARIX was discontinued.  The reporting nurse considered the events to be related to vaccination with PEDIARIX.
vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site pain). At the time of the report, VACCINATION SITE PAIN (vaccination site pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow-up reported: NNI
Benadryl, 50 mg, Oral  DEPO-Medrol, 80 mg, IM  DuoNeb, 0.5 mg, NEB  LORazepam, 2 mg, IV  methylPREDNISolone sodium succinate 125 mg preservative-free injection, 62.5 mg, IV Push  Singulair, 10 mg, Oral  Sodium Chloride 0.9% Bolus, 1000 mL, IV Piggyback  Zofran ODT, 4 mg, Oral 1. Acute interstitial pneumonitis J84.114  Patient did receive Benadryl 50 mg PO, Zofran 4 mg ODT, Depo-Medrol 80 mg IM, Solumedrol 62.5 mg IVP, NS 1L bolus IV, Ativan 2 mg IVP, and a Duoneb nebulizer treatment of symptoms while in the ED. 2. Pneumonitis, hypersensitivity J67.9  Patient accepted for ED to ED transfer by Dr. (ER attending) at 1555. Patient transferred by air to another ED.
Swelling in upper arm around injections site.  Pain severe enough to limit movement in left arm.
More than 24 hours after vaccinnation I started having high fever. The fever was unusual. I had it for about 14 hours. Throughout the night I was soaked with sweat that I had to change three clothes before daybreak. The fever was so intense that it elicited rigor. I was shaking in the bed.  Besides, I contacted Corona virus at first week of November 2020. I was diagnosed after my emergency visit to hospital. I recover naturally without another emergency visit. I only took Advil and inhaled hot steams mixed with lemon and garlic. Counld my antibody be the reason for my intense fever experience after vaccinnation?
he got the shingles; This is a spontaneous report from a Pfizer Sponsored Program. A non-contactable consumer (patient's wife) reported that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. None medical history. The patient's concomitant medications were not reported. The patient experienced shingles on an unspecified date with outcome of unknown. The reporter asked if her husband can still take his second covid vaccine on Friday since he got the shingles after getting the first covid vaccine. She clarified that the husband did not have shingles before covid vaccine.  No follow-up attempts are possible; Information related to batch/Lot number could not be requested.
Information has been received from a nurse practitioner and a nurse concerning one of her patient's friends who on unknown date was vaccinated with the third dose of GARDASIL (LOT # was not provided). After receiving the vaccination, the patient was admitted to hospital. At the time of this report, the patient was still in the hospital with a "serious" condition. Additional information is not expected.
was reported that patient experienced:confirmed covid.; was reported that patient experienced:confirmed covid.; This is a spontaneous report from a non-contactable other healthcare professional (HCP). This non-contactable other HCP was reporting same events under the same suspect product for two patients. This is one of two reports.  An around 50-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiration date were unknown) as the 2nd dose, single dose for COVID-19 immunization. The patient previously received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunization. Relevant medical history included that the patient was obese and had multiple sclerosis (MS), both from an unknown date and unknown if ongoing. Concomitant medication included ocrelizumab (OCREVUS) taken for an unspecified indication, start and stop date were not reported. It was reported that patient experienced: confirmed covid on an unspecified date. It was further reported that there were two MS patients currently more than (>) 1 month post second vaccine (both Pfizer) with lab confirmed covid (positive); both with medically significant illness, neither required hospitalization. The outcome of the event was unknown.  No follow-up attempts are possible, information about batch/lot number cannot be obtained. No further information is expected.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be excluded for reported "experienced: confirmed covid".,Linked Report(s) : US-PFIZER INC-2021641519 same reporter, drug, and event; different patient
Patient reported that she passed out after her first dose. Advised patient to remain seated at vaccine station for her post observation time. After vaccine was administered the RN gave the patient a can of grape juice to prevent a possible vasovagal response. Patient remained at vaccine station and interacted with staff without any issues. Patient went back to the facility office to continue work at her desk. RN was drawing vaccine when we heard patient begin to vomit. RN and PA went to assist patient, patient eased herself to the floor, head did not hit the ground. patient was kept on her side as she was vomitting and dry heaving (vomiting and dry heaving continued for about 3 minutes) and patient then fainted for about 15 seconds. Paramedics were called and arrived on the scene within 10 minutes. PA obtained vitals and heart rate and no concern on those vitals. Patient complained that her head was hurting and RN and paramedic assisted patient in a sitting position and then transferred to stretcher/gurney. EMS then took over the situation patient was responding to questions the paramedics were asking and patient was transferred to hospital for further evaluation.
The caller reports that her husband felt very tired after receiving each dose of the Moderna Covid-19 vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (The caller reports that her husband felt very tired after receiving each dose of the Moderna Covid-19 vaccine.) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (The caller reports that her husband felt very tired after receiving each dose of the Moderna Covid-19 vaccine.). At the time of the report, FATIGUE (The caller reports that her husband felt very tired after receiving each dose of the Moderna Covid-19 vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Diarrhea, Swollen Tongue, shortness of breath, droop to one side of the face, loss of appetite, fatigue.
Feeling tired, nauseated, vomiting. She fell and had to have assistance getting up, Afterwards, had some weakness in legs. She did have COVID in July. Still having some weakness. No pain.
Cold sweats starting Thursday evening, Friday sweating at night, and Saturday morning ~6:00 am with chest pain and sweats. Pain intensified and brought to Urgent Care at 8 am where an EKG was completed and showed signs of a heart attack. Was rushed to Hospital Emergency room. Admitted and examined. Completed an angiogram and noted that there was a blood clot that appeared to dissolve. Troponin levels were high showing damage to the left artery.  Spent the night in the hospital. Prescribed medication for cholesterol, blood thinners, and seeing a cardiologist.
This is in follow-up to report (s) previously submitted 3/14/2007. Information has been received from a physician via a company representative, concerning a female patient who was vaccinated with either a first dose or second dose of GARDASIL. Subsequently the patient experienced nausea after vaccination. The patient recovered within a day. The patient sought unspecified medical attention. Additional information has been requested. Follow up information confirmed that no known patient was identified or involved with the event. Therefore, WAES # 0702USA03637 is being deleted from our files. This report was previously sent in a monthly submission to PLA V501 on 14-MAR-2007. This is in follow-up to report (s) previously submitted on 3/14/2007. Information has been received froma physician via a company representative, concerning a female patient who was vaccinated with either a first dose or GARDASIL. Subsequently the patient experienced nausea after vaccination. The patient recovered within a day. The patient sought unspecified medical attention. Follow up information confirmed that no known patient was identified or involved with the event. Therefore, WAES # 0702USA03637 is being deleted from our files. This report was previously sent in a monthly submission to PLA V501 on 14-MAR-2007.
Pt received his booster, said he felt fine and walked away.  The patient was with his grandmother and passed out on his way out of the store. He hit his head and appeared to look like he had a seizure.  The EMTs evaluated him and said they feel it was just do to anxiety.  The grandmother mentioned he had experienced this a long time ago while receiving a vaccination
4 mo old female who had PCV 13 IM in left anterior thigh and PENTACEL IM in right anterior thigh on 4/12/11. Within 24 hrs after vaccines mom noticed multiple bumps with redness on both thighs that spread superiorly. No problems breathing, no lip or tongue swelling, no itching, no fevers. Pt received these vaccines 2 months ago without problems.
This spontaneous report as received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 07-JUN-2010, patient received improperly stored VARIVAX dose 2, from batch/lot #665413/1128Y (expiry date, dose units, route and anatomical location were not specified) (incorrect product storage). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
Patient received a dose while in the Hospital on 10/08/2022, Patient sister is her caregiver and stated that she was not made aware of the flu shot that her sister had received.  Staff found out when they were attempting to put it into the system. Patient and her sister notified.
Bumps entire body started on 04/16/2005. Fever x 4 days 101-103 degrees Fahrenheit.
Patient felt tightness on her face and dizziness about 45min-1 hour after administration. She described it as cheek, nose and chin on fire, About an hour and half after the administration, patient felt the neck getting a little swollen and she felt a bit hard to swallow.  Symptoms lasted for about several hours. Patient feels like she has recovered about 90%  20 hours post vaccine.
Itchy face for most of the day after day of vaccination Rash and hives then developed on entirety face.  Started underneath the eyes and spread down the face to chin.  Quickly developed over the course of an hour and quickly faded after taking antihistamine and applying hydrocortisone.
This spontaneous report was received from a medical assistant who was referring to a patient of unknown age and gender. There was no information regarding the patient's concomitant medications, pertinent medical history, drug reactions or allergies provided. On 19-MAY-2017, the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX 23 (dose, route of administration were not reported) lot # L040053, expiration date 10-MAY-2017 for prophylaxis. There was no adverse effect reported. No product quality complaint was involved. Additional information has been requested.
Cellulitis lt upper arm 1-2 days p/rec'd immun t 101.4; placed on Duracef per PMD;
Flu-like Symptoms; feverish; nausea; achy; low energy; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 57-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2019-2020 season) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 27th September 2019, the patient received the 2nd dose of Fluarix Tetra 2019-2020 season and the 2nd dose of Shingrix. On 27th September 2019, 5 hrs after receiving Fluarix Tetra 2019-2020 season and Shingrix, the patient experienced influenza-like symptoms, fever, nausea, pain and energy decreased. On 30th September 2019, the outcome of the influenza-like symptoms was resolved with sequelae. On an unknown date, the outcome of the fever, nausea, pain and energy decreased were resolved with sequelae.   It was unknown if the reporter considered the influenza-like symptoms, fever, nausea, pain and energy decreased to be related to Fluarix Tetra 2019-2020 season and Shingrix.  Additional information received were as follows: The patient received 2nd dose Shingrix in his right arm and Fluarix Quadrivalent in his left arm and he experienced flu-like symptoms approximately 5-6 hours following vaccination that consisted of severe nausea, feverish, achy, and low energy.  The caller reports flu-like symptoms lasted approximately 2 days and was resolved. The reporter consented to follow up. The caller was a GlaxoSmithKline employee who did not work for the field.  The caller was the wife of the patient in this report. This report is 2 of 2, reported by same reporter.
Started having rash that developed 1 day after receiving second dose of vaccine. Affecting bilateral arms, legs, back, stomach, and breast. Initially had rash form just on right forearm after 1st vaccine given on 1/8/21 at same site and facility- Lot 027L20A.
sight tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sight tenderness at injection site) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PAIN (sight tenderness at injection site). At the time of the report, VACCINATION SITE PAIN (sight tenderness at injection site) had resolved.            Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant and treatment information not provided